Klara Dickinson

Klara Dickinson currently serves as Chief Regulatory and Compliance Officer and Senior Vice President at CymaBay Therapeutics, a position held since June 2017. Prior to this role, Klara Dickinson was Senior Vice President and Chief Regulatory Officer at Anthera Pharmaceuticals from January 2015 to June 2017, and served as Senior Vice President of Regulatory Affairs and Compliance at Hyperion Therapeutics from September 2007 to July 2014. Earlier in the career, Klara Dickinson held the role of Vice President of Regulatory Affairs at CoTherix Inc. from January 2004 to January 2007, and worked at Johnson and Johnson, Scios as Associate Director from 1997 to 2003, as well as in a similar capacity at Scios from 1994 to 2003. Klara Dickinson earned a Bachelor of Science in Biology from the University of Providence and a later Bachelor of Science degree from the University of Great Falls.